XNJP 📈 Xtrackers Nikkei 225 UCITS - Overview
Exchange: SW • Country: Switzerland • Currency: JPY • Type: Etf • ISIN: LU0839027447 • Japan Large-Cap Equity
XNJP: Japanese Stocks, Equities, Index Funds
The Xtrackers Nikkei 225 UCITS ETF 1D, listed on the SIX Swiss Exchange under the ticker SW:XNJP, is designed to track the performance of the Nikkei Stock Average Index, a widely recognized benchmark for the Japanese stock market. This index comprises 225 stocks listed on the Tokyo Stock Exchange First Section, providing a broad representation of the Japanese equity market. The index is periodically reviewed to ensure that it remains a relevant and accurate reflection of the market, with a focus on maintaining sector balance and liquidity. This review process involves assessing the trading volume and price fluctuations of the constituent shares over a five-year period, aiming to select the most liquid and representative stocks.
The fund's investment strategy involves replicating the Nikkei Stock Average Index by purchasing all, or in exceptional cases, a substantial number of the shares in the index, in the same proportion as they are weighted in the index. This approach is designed to provide investors with a cost-effective and efficient way to gain exposure to the Japanese stock market. The Sub-Portfolio Manager of the fund, Deutsche Asset Management (UK) Limited, is responsible for managing the fund's portfolio and ensuring that it tracks the underlying index as closely as possible. With its domicile in Luxembourg and ISIN code LU0839027447, this ETF offers investors a transparent and regulated way to access the Japanese equity market.
As a Japan Large-Cap Equity ETF, the Xtrackers Nikkei 225 UCITS ETF 1D provides investors with a targeted exposure to the Japanese large-cap segment, which is dominated by well-established companies with a strong market presence. The fund's underlying index, the Nikkei Stock Average Index, is a price-weighted index, meaning that the stocks with the highest market capitalization have a greater influence on the index's performance. This ETF category is suitable for investors seeking to gain exposure to the Japanese equity market, with a focus on large-cap stocks, and can be used as a building block for a diversified investment portfolio.
Additional Sources for XNJP ETF
XNJP ETF Overview
Market Cap in USD | 1,559m |
Category | Japan Large-Cap Equity |
TER | 0.11% |
IPO / Inception | 2013-01-25 |
XNJP ETF Ratings
Growth 5y | 73.2% |
Fundamental | - |
Dividend | 42.8% |
Rel. Strength Industry | 658 |
Analysts | - |
Fair Price Momentum | 4077.78 JPY |
Fair Price DCF | - |
XNJP Dividends
Dividend Yield 12m | 1.38% |
Yield on Cost 5y | 2.44% |
Annual Growth 5y | 13.37% |
Payout Consistency | 95.7% |
XNJP Growth Ratios
Growth Correlation 3m | 24.3% |
Growth Correlation 12m | 35.3% |
Growth Correlation 5y | 85.7% |
CAGR 5y | 13.50% |
CAGR/Mean DD 5y | 2.23 |
Sharpe Ratio 12m | 0.69 |
Alpha | 0.31 |
Beta | 0.66 |
Volatility | 16.65% |
Current Volume | 6.8k |
Average Volume 20d | 2.4k |
As of December 22, 2024, the stock is trading at JPY 4030.50 with a total of 6,808 shares traded.
Over the past week, the price has changed by -1.61%, over one month by +2.55%, over three months by +4.51% and over the past year by +18.61%.
Yes. Based on ValueRay Analyses, Xtrackers Nikkei 225 UCITS (SW:XNJP) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 73.19 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XNJP as of December 2024 is 4077.78. This means that XNJP is currently overvalued and has a potential downside of 1.17%.
Xtrackers Nikkei 225 UCITS has no consensus analysts rating.
According to ValueRays Forecast Model, XNJP Xtrackers Nikkei 225 UCITS will be worth about 4485.6 in December 2025. The stock is currently trading at 4030.50. This means that the stock has a potential upside of +11.29%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 4485.6 | 11.3% |